The Impact of Fortetropin Supplementation on Dogs Recovering from TPLO Surgery



The Impact of Fortetropin Supplementation on Dogs Recovering from TPLO Surgery

08 Nov 2019
Innovation Showcase 1

The impact of the nutrition product, Fortetropin on muscle atrophy in dogs recovering from TPLO surgery was evaluated in a randomized, double-blinded, placebo-controlled study involving 100 dogs. Fortetropin is an advanced nutrition product that is manufactured using a proprietary process that involves non-thermal pasteurization and freeze drying. Dogs in the Fortetropin and placebo (cheese powder) groups were evaluated at baseline and during the 8 and 12 week post-operative periods. Following surgery, dogs experienced 8 weeks of forced exercise restriction, gradually resuming physical activity during weeks 9 - 12. Evaluation parameters included: thigh circumference measurements, stance force analysis, serum myostatin and C-reactive protein concentration measurements, ultrasonographic assessments of thigh and epaxial muscle thickness, and muscle condition scoring. During the period of forced exercise restriction from week 0 - 8, when comparing Fortetropin® supplementation to placebo: 1) Fortetropin® prevented a rise in serum myostatin levels, 2) Fortetropin® minimized the loss of muscle mass as measured by thigh circumference in the affected and unaffected limbs and 3) Fortertropin® supplemented dogs had a more significant improvement in percent of weight supported by the affected limb as determined by force plate stance analysis (more rapid return to normal stance force distribution).

Education Partners


Platinum Sponsors


Gold Sponsors


Silver Partners